U.S. markets open in 1 hour 27 minutes

Infinity Q Diversified Alpha Fund Investor Class (IQDAX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
12.65+0.02 (+0.16%)
At close: 8:00PM EDT
Full screen
Previous Close12.63
YTD Return0.96%
Expense Ratio (net)2.46%
CategoryMultialternative
Last Cap Gain0.00
Morningstar Rating★★★★
Morningstar Risk RatingAverage
Sustainability RatingN/A
Net Assets1.76B
Beta (5Y Monthly)-0.34
Yield0.00%
5y Average ReturnN/A
Holdings Turnover23.00%
Last Dividend0.00
Average for CategoryN/A
Inception DateSep 30, 2014
  • IQDNX & IQDAX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Infinity Q Diversified Alpha Fund Institutional & Investor Class of Class Action and Lead Plaintiff Deadline: April 27, 2021
    GlobeNewswire

    IQDNX & IQDAX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Infinity Q Diversified Alpha Fund Institutional & Investor Class of Class Action and Lead Plaintiff Deadline: April 27, 2021

    NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Infinity Q Diversified Alpha Fund Institutional Class (NASDAQ: IQDNX) and Infinity Q Diversified Alpha Fund Investor Class (NASDAQ: IQDAX), collectively (“Infinity Q” or the “Company”) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Infinity Q securities between December 21, 2018 through February 22, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/iqdnx. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) Infinity Q’s Chief Investment Officer made adjustments to certain parameters within the third-party pricing model that affected the valuation of the swaps held by the Fund; (2) consequently, Infinity Q would not be able to calculate NAV correctly; (3) as a result, the previously reported NAVs were unreliable; (4) because of the foregoing, the Fund would halt redemptions and liquidate its assets; and (5) as a result, the Prospectuses were materially false and/or misleading and failed to state information required to be stated therein. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/iqdnx or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Infinity Q you have until April 27, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

  • ACCESSWIRE

    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Infinity Q Diversified Alpha Fund (IQDAX; IQDNX) Investors to April 27th Deadline in Securities Class Action, Encourages Investors with Losses to Contact the Firm Now

    SAN FRANCISCO, CA / ACCESSWIRE / April 26, 2021 / Hagens Berman urges Infinity Q Diversified Alpha Fund (NASDAQ:IQDAX)(NASDAQ:IQDNX) (the "Fund") investors with significant losses to submit your losses now. A securities fraud class action with an April 27th lead plaintiff deadline has been filed after advisor Infinity Q Capital Management admitted to mispricing the Fund's NAV resulting in the Fund being liquidated.

  • DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
    GlobeNewswire

    DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

    LOS ANGELES, April 26, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. AgEagle Aerial Systems Inc. (NYSE: UAVS)Class Period: September 3, 2019 – February 18, 2021Lead Plaintiff Deadline: April 27, 2021 The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public’s understanding about a partnership with Amazon, defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. Infinity Q Diversified Alpha Fund Investor Class shares (NASDAQ: IQDAX) or Institutional Class shares (NASDAQ: IQDNX)Class Period: December 21, 2018 – February 22, 2021Lead Plaintiff Deadline: April 27, 2021 The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Infinity Q’s Chief Investment Officer made adjustments to certain parameters within the third-party pricing model that affected the valuation of the swaps held by the Fund; (2) consequently, Infinity Q would not be able to calculate NAV correctly; (3) as a result, the previously reported NAVs were unreliable; (4) because of the foregoing, the Fund would halt redemptions and liquidate its assets; and (5) as a result, the prospectuses were materially false and/or misleading and failed to state information required to be stated therein. Aquestive Therapeutics, Inc. (NASDAQ: AQST)Class Period: December 2, 2019 – September 25, 2020Lead Plaintiff Deadline: April 30, 2021 The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA's approval prospects; (3) as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Follow us for updates on Twitter: twitter.com/FRC_LAW. To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, 310-914-5007fcruz@frankcruzlaw.comwww.frankcruzlaw.com